Metastatic Colon Cancer, Version 3.2013

被引：117

作者：

Benson, Al B., III ^{[1
]}

Bekaii-Saab, Tanios ^{[2
,3
]}

Chan, Emily ^{[4
]}

Chen, Yi-Jen

Choti, Michael A. ^{[5
]}

Cooper, Harry S. ^{[6
]}

Engstrom, Paul F. ^{[6
]}

Enzinger, Peter C.

Fakih, Marwan G. ^{[7
]}

Fenton, Moon J. ^{[8
]}

Fuchs, Charles S.

Grem, Jean L. ^{[9
]}

Hunt, Steven ^{[10
,11
]}

Kamel, Ahmed ^{[12
]}

Leong, Lucille A.

Lin, Edward ^{[13
]}

May, Kilian Salerno ^{[14
]}

Mulcahy, Mary F. ^{[1
]}

Murphy, Kate

Rohren, Eric ^{[15
]}

Ryan, David P. ^{[16
]}

Saltz, Leonard ^{[17
]}

Sharma, Sunil ^{[18
]}

Shibata, David ^{[19
]}

Skibber, John M. ^{[15
]}

Small, William, Jr. ^{[1
]}

Sofocleous, Constantinos T. ^{[17
]}

Venook, Alan P. ^{[20
]}

Willett, Christopher G. ^{[21
]}

Gregory, Kristina M. ^{[22
]}

Freedman-Cass, Deborah A. ^{[22
]}

机构：

[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[2] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[3] Solove Res Inst, Columbus, OH USA

[4] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[5] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[6] Fox Chase Canc Ctr, Philadelphia, PA USA

[7] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[8] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[9] UNMC Eppley Canc Ctr, Nebraska Med Ctr, Omaha, NE USA

[10] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[11] Washington Univ, Sch Med, St Louis, MO 63130 USA

[12] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL USA

[13] Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Alliance, OH USA

[14] Roswell Pk Canc Inst, Buffalo, NY USA

[15] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[16] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[17] Mem Sloan Kettering Canc Ctr, New York, NY USA

[18] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[19] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[20] UCSF Helen Diller Family, Ctr Comprehens Canc, San Francisco, CA USA

[21] Duke Canc Inst, Durham, NC USA

[22] Natl Comprehens Canc Network, Toronto, ON, Canada

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2013年 / 11卷 / 02期

关键词：

HIGH-DOSE LEUCOVORIN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; ADVANCED COLORECTAL-CANCER; PHASE-III TRIAL; FLUOROURACIL PLUS LEUCOVORIN; RANDOMIZED-TRIAL; PERITONEAL CARCINOMATOSIS; CYTOREDUCTIVE SURGERY; 1ST-LINE TREATMENT; SYSTEMIC CHEMOTHERAPY;

D O I：

10.6004/jnccn.2013.0022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, perioperative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy. (JNCCN 2013;11:141-152)

引用

页码：141 / 152

页数：12

共 71 条

[1] Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].

Amado, Rafael G. ;

Wolf, Michael ;

Peeters, Marc ;

Van Cutsem, Eric ;

Siena, Salvatore ;

Freeman, Daniel J. ;

Juan, Todd ;

Sikorski, Robert ;

Suggs, Sid ;

Radinsky, Robert ;

Patterson, Scott D. ;

Chang, David D. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634

[2] CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer [J].

André, T ;

Louvet, C ;

Maindrault-Goebel, F ;

Couteau, C ;

Mabro, M ;

Lotz, JP ;

Gilles-Amar, V ;

Krulik, M ;

Carola, E ;

Izrael, V ;

de Gramont, A .

EUROPEAN JOURNAL OF CANCER, 1999, 35 (09) :1343-1347

[3]

[Anonymous], 2012, ZALTRAP ZIV AFL PACK

[4] Shed alcam as a biomarker for urogenital cancers [J].

Arnold, Shanna ;

Jones-Paris, Celestial ;

Hansen, Amanda Georgia ;

Fadare, Oluwole ;

Clark, Peter ;

Zijlstra, Andries .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30)

[5] Chemotherapy and regional therapy of hepatic colorectal metastases: Expert consensus statement [J].

Bartlett, David L. ;

Berlin, Jordan ;

Lauwers, Gregory Y. ;

Messersmith, Wells A. ;

Petrelli, Nicholas J. ;

Venook, Alan P. .

ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (10) :1284-1292

[6] RANDOMIZED COMPARISON OF 2 SCHEDULES OF FLUOROURACIL AND LEUCOVORIN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER [J].

BUROKER, TR ;

OCONNELL, MJ ;

WIEAND, HS ;

KROOK, JE ;

GERSTNER, JB ;

MAILLIARD, JA ;

SCHAEFER, PL ;

LEVITT, R ;

KARDINAL, CG ;

GESME, DH .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) :14-20

[7] Survival Outcomes of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Treated in US Community Oncology [J].

Cartwright, Thomas H. ;

Yim, Yeun Mi ;

Yu, Elaine ;

Chung, Hsingwen ;

Halm, Melissa ;

Forsyth, Michael .

CLINICAL COLORECTAL CANCER, 2012, 11 (04) :238-246

[8] Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer [J].

Cassidy, Jim ;

Clarke, Stephen ;

Diaz-Rubio, Eduardo ;

Scheithauer, Werner ;

Figer, Arie ;

Wong, Ralph ;

Koski, Sheryl ;

Lichinitser, Mikhail ;

Yang, Tsai-Shen ;

Rivera, Fernando ;

Couture, Felix ;

Sirzen, Florin ;

Saltz, Leonard .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) :2006-2012

[9] A 'modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer [J].

Cheeseman, SL ;

Joel, SP ;

Chester, JD ;

Wilson, G ;

Dent, JT ;

Richards, FJ ;

Seymour, MT .

BRITISH JOURNAL OF CANCER, 2002, 87 (04) :393-399

[10]

Chen LM, 2011, ATL AMB PERVAS INTEL, V4, P1, DOI 10.1097/COC.0b013e3181fe41ed

← 1 2 3 4 5 6 7 8 →